Research News

Spironolactone made no difference to patients with mild diastolic heart failure

BMJ 2013; 346 doi: (Published 27 February 2013) Cite this as: BMJ 2013;346:f1290

OpenUrlCrossRefPubMedWeb of Science

Spironolactone failed to improve symptoms, quality of life, or exercise capacity in a recent placebo controlled trial of patients with heart failure caused by diastolic dysfunction. The aldosterone antagonist improved diastolic function and prognostic biomarkers, but not enough to …

View Full Text

Sign in

Log in through your institution